Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 16951 - 17000 of 39437 in total
PDB ID ▼ UniProt ID Title Descriptor
6UGY 6UGY Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6UGY P0DOX5 Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6UGY 6UGY Crystal structure of the Fc fragment of anti-TNFa antibody infliximab (Remicade) in a primative orthorhombic crystal form, Lot C
6UGX P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGX 6UGX Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGX P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGX 6UGX Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a primative orthorhombic crystal form, Lot A
6UGW P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UGW 6UGW Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UGW P0DOX5 Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UGW 6UGW Crystal structure of the Fc fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A
6UG9 6UG9 Complex of ch28/11 Fab and SSEA-4 (hexagonal form)
6UG8 6UG8 Complex of ch28/11 Fab and SSEA-4 (monoclinic form)
6UG7 6UG7 Complex of ch28/11 Fab and SSEA-4 (tetragonal form)
6UFL G0FQ07 Crystal structure of a GH128 (subgroup I) endo-beta-1,3-glucanase (E199Q mutant) from Amycolatopsis mediterranei (AmGH128_I) in the complex with laminarihexaose
6UEU D9N168 Crystal structure of BF DNA polymerase F710Y mutant bound to tetrahydrofuran and dATP
6UEA P01877 Structure of pentameric sIgA complex Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UEA P01833 Structure of pentameric sIgA complex Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UEA P01591 Structure of pentameric sIgA complex Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE9 P01877 Structure of tetrameric sIgA complex (Class 2) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE9 P01833 Structure of tetrameric sIgA complex (Class 2) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE9 P01591 Structure of tetrameric sIgA complex (Class 2) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE8 P01877 Structure of tetrameric sIgA complex (Class 1) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE8 P01833 Structure of tetrameric sIgA complex (Class 1) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE8 P01591 Structure of tetrameric sIgA complex (Class 1) Immunoglobulin heavy constant alpha 2, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE7 P01876 Structure of dimeric sIgA complex Immunoglobulin heavy constant alpha 1, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE7 P01833 Structure of dimeric sIgA complex Immunoglobulin heavy constant alpha 1, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UE7 P01591 Structure of dimeric sIgA complex Immunoglobulin heavy constant alpha 1, Polymeric immunoglobulin receptor, Immunoglobulin J chain
6UDK S6B2B6 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK 6UDK HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6B2B6 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK 6UDK HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q8N355 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q8N355 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6C4S0 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK S6C4S0 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q6PJF2 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDK Q6PJF2 HIV-1 bNAb 1-55 in complex with modified BG505 SOSIP-based immunogen RC1 and 10-1074 RC1 variant of HIV-1 Env glycoprotein gp120, 10-1074 Fab Heavy Chain,10-1074 Fab Light Chain,1-55 Fab Heavy Chain, 1-55 Fab Light Chain,RC1 variant of HIV-1 Env glycoprotein gp41
6UDJ S6B2B6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ 6UDJ HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ S6B2B6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ 6UDJ HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q8N355 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q8N355 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q2N0S6 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q6PIL8 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDJ Q6PIL8 HIV-1 bNAb 1-18 in complex with BG505 SOSIP.664 and 10-1074 10-1074 Fab Heavy Chain,1-18 Fab Light Chain, 10-1074 Fab Light Chain,1-18 Fab Heavy Chain, Envelope glycoprotein gp41, HIV-1 envelope glycoprotein gp120
6UDA M4M0W3 Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 CH505.N279K.G458Y.SOSIP.664 gp120, CH235 UCA heavy chain Fab, CH505.N279K.G458Y.SOSIP.664 gp41, CH235 UCA light chain Fab
6UDA 6UDA Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 CH505.N279K.G458Y.SOSIP.664 gp120, CH235 UCA heavy chain Fab, CH505.N279K.G458Y.SOSIP.664 gp41, CH235 UCA light chain Fab
6UDA Q2N0S5 Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 CH505.N279K.G458Y.SOSIP.664 gp120, CH235 UCA heavy chain Fab, CH505.N279K.G458Y.SOSIP.664 gp41, CH235 UCA light chain Fab
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024